Environmental fungicides and triazole resistance in Aspergillus

被引:69
作者
Bowyer, Paul
Denning, David W.
机构
[1] Univ S Manchester Hosp, Natl Aspergillosis Ctr, Manchester M23 9LT, Lancs, England
[2] Univ Manchester, Inst Inflammat & Repair, Manchester, Lancs, England
[3] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
基金
英国生物技术与生命科学研究理事会;
关键词
fungicide; resistance; triazole; Aspergillus fumigatus; CHRONIC PULMONARY ASPERGILLOSIS; AZOLE RESISTANCE; CYP51A GENE; FUMIGATUS; POSACONAZOLE; VORICONAZOLE; THERAPY; TR/L98H; PROPHYLAXIS; FLUCONAZOLE;
D O I
10.1002/ps.3567
中图分类号
S3 [农学(农艺学)];
学科分类号
0901 ;
摘要
Fungal diseases are problematic in both human health and agriculture. Treatment options are limited and resistance may emerge. The relatively recent recognition of triazole resistance in Aspergillus fumigatus has prompted questioning of the origin of resistance. While multiple mechanisms are described in clinical isolates from triazole-treated patients, some de novo resistance is also recognised, especially attributable to TR34/L98H. Such strains probably arose in the environment, and, indeed, multiple studies have now demonstrated TR34/L98H triazole resistance strains of A. fumigatus from soil. Docking and other in vitro studies are consistent with environmental resistance induction through exposure to certain triazole fungicides, notably difenoconazole, propiconazole, epoxiconazole, bromuconazole and tebuconazole. This article addresses the potential implications of this issue for both human health and food security. (c) 2013 Society of Chemical Industry
引用
收藏
页码:173 / 178
页数:6
相关论文
共 45 条
[1]  
[Anonymous], 2013, EUR CTR DIS PREV CON
[2]   Rapid, high-throughput, multiplex, real-time PCR for identification of mutations in the cyp51A gene of Aspergillus fumigatus that confer resistance to itraconazole [J].
Balashov, SV ;
Gardiner, R ;
Park, S ;
Perlin, DS .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (01) :214-222
[3]   Sterol Regulatory Element Binding Proteins in Fungi: Hypoxic Transcription Factors Linked to Pathogenesis [J].
Bien, Clara M. ;
Espenshade, Peter J. .
EUKARYOTIC CELL, 2010, 9 (03) :352-359
[4]   Azole antifungal resistance today: Focus on Aspergillus [J].
Bowyer P. ;
Moore C.B. ;
Rautemaa R. ;
Denning D.W. ;
Richardson M.D. .
Current Infectious Disease Reports, 2011, 13 (6) :485-491
[5]   Hidden Killers: Human Fungal Infections [J].
Brown, Gordon D. ;
Denning, David W. ;
Gow, Neil A. R. ;
Levitz, Stuart M. ;
Netea, Mihai G. ;
White, Theodore C. .
SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (165)
[6]   Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009 [J].
Bueid, Ahmed ;
Howard, Susan J. ;
Moore, Caroline B. ;
Richardson, Malcolm D. ;
Harrison, Elizabeth ;
Bowyer, Paul ;
Denning, David W. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (10) :2116-2118
[7]   Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial [J].
Cadranel, J. ;
Philippe, B. ;
Hennequin, C. ;
Bergeron, A. ;
Bergot, E. ;
Bourdin, A. ;
Cottin, V. ;
Jeanfaivre, T. ;
Godet, C. ;
Pineau, M. ;
Germaud, P. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (11) :3231-3239
[8]   Voriconazole and Posaconazole Improve Asthma Severity in Allergic Bronchopulmonary Aspergillosis and Severe Asthma with Fungal Sensitization [J].
Chishimba, Livingstone ;
Niven, Robert M. ;
Cooley, John ;
Denning, David W. .
JOURNAL OF ASTHMA, 2012, 49 (04) :423-433
[9]   Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India [J].
Chowdhary, Anuradha ;
Kathuria, Shallu ;
Randhawa, Harbans S. ;
Gaur, Shailendra N. ;
Klaassen, Corne H. ;
Meis, Jacques F. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (02) :362-366
[10]   Are azole fungicides losing ground against Septoria wheat disease?: Resistance mechanisms in Mycosphaerella graminicola [J].
Cools, Hans J. ;
Fraaije, Bart A. .
PEST MANAGEMENT SCIENCE, 2008, 64 (07) :681-684